9999999995-21-003891.txt : 20211015
9999999995-21-003891.hdr.sgml : 20211015
20211015001520
ACCESSION NUMBER: 9999999995-21-003891
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20211014
DATE AS OF CHANGE: 20211015
EFFECTIVENESS DATE: 20211014
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc.
CENTRAL INDEX KEY: 0001806310
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 843199512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-260069
FILM NUMBER: 211324687
BUSINESS ADDRESS:
STREET 1: 3000 PEGASUS PARK DRIVE
STREET 2: SUITE 1430
CITY: DALLAS
STATE: TX
ZIP: 75247
BUSINESS PHONE: (214) 612-0000
MAIL ADDRESS:
STREET 1: 3000 PEGASUS PARK DRIVE
STREET 2: SUITE 1430
CITY: DALLAS
STATE: TX
ZIP: 75247
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2021-10-14
16:00:00
0001806310
Taysha Gene Therapies, Inc.
333-260069